Menopause Supplements Market Size, Share & Trends Analysis Report By Type (Hormonal Supplements, Non-hormonal Supplements), By Dosage Form (Tablet & Capsule, Powder, Liquid, Others), By Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies, Online Stores, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Menopause Supplements Market Size & Growth Analysis

The global menopause supplements market size was valued at USD 18.66 billion in 2025 and is projected to grow from USD 19.69 billion in 2026 to USD 30.32 billion by 2034, registering a CAGR of 5.54% during the forecast period from 2026 to 2034. North America dominated the menopause supplements market with a market share of 39.62% in 2025.

The global menopause supplements market encompasses a diverse range of product types, including hormonal supplements and non-hormonal supplements, which are further categorised into herbal formulations, vitamins and minerals, and others. These supplements are available in various forms, including tablets and capsules, powders, liquids, and other dosage forms, catering to different consumer preferences and enhancing adherence to supplementation regimens. Moreover, these products are distributed through multiple channels such as drug stores and retail pharmacies, hospital pharmacies, online platforms, and other sales outlets, ensuring broad consumer accessibility.

Type Insights

The non-hormonal supplements segment dominated the market in 2025. This growth is driven by the rising inclusion of menopause wellness programs within corporate health initiatives. Employers are increasingly adopting non-hormonal supplements as part of workplace wellness offerings to support female employees experiencing menopausal symptoms such as fatigue, anxiety, and poor concentration. This proactive approach not only improves workforce productivity and well-being but also promotes broader acceptance of menopause supplements.

The hormonal supplements segment is estimated to register the fastest CAGR of 6.27% during the forecast period, owing to the increasing demand for bioidentical hormone formulations that closely mimic natural estrogen and progesterone. Rising medical endorsement of hormone therapy for managing severe menopausal symptoms such as hot flashes, night sweats, and mood instability is further driving adoption and supporting market growth.

Request Customizationto receive a tailored report.

Dosage Form Insights

The tablet & capsule segment dominated the market with the highest revenue share of 32.78% in 2025. This growth is attributed to their extended shelf life, accurate dosage delivery, and portability, which make them the most convenient and preferred format for consumers seeking consistent and reliable menopause symptom management solutions.

The liquid segment is projected to register the fastest CAGR of 6.84% from 2026-2034, due to its faster absorption rate and ease of consumption among older women with swallowing difficulties, driving increased preference for liquid formulations in menopause supplement products.

Distribution Channel Insights

The drug stores and retail pharmacies segment dominated the market with the highest revenue share of 37.61% in 2025. This growth is augmented by increasing use of loyalty and subscription programs by pharmacy chains, encouraging repeat purchases and consistent supplement use, thereby enhancing customer retention and driving higher sales.

The online stores segment is estimated to register the fastest CAGR during the forecast period, due to the expansion of regional e-commerce platforms and cross-border shipping, which allows consumers in remote areas to access a wider variety of menopause supplements not readily available in local retail pharmacies.

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America dominated the market in 2025, accounting for 39.62% market share. This growth is augmented by the region’s strong research and development capabilities, enabling the development of scientifically validated and clinically tested formulations. Continuous innovation supported by leading universities and biotechnology firms enhances product credibility, driving consumer trust and market expansion.

U.S. menopause supplements market is stimulated by the rising influence of health and wellness awareness campaigns. Initiatives by government bodies, healthcare organizations, and media platforms are educating women about menopause management, encouraging proactive supplement use. This increased awareness is boosting demand for over-the-counter and clinically supported products across the country.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Market Insights

Asia Pacific is emerging as a fastest growing region with a CAGR of 7.23% from 2026 to 2034, owing to the rising demand for ayurvedic and traditional herbal formulations tailored to local preferences. Women in countries such as India, China, and Japan increasingly seek region-specific, culturally trusted botanical supplements that combine modern science with traditional wellness practices, creating a unique growth segment within the market.

China menopause supplements market growth is supported by the integration of traditional Chinese medicine (TCM) with modern supplement formulations. Products combining herbs like Dong Quai and Rehmannia with vitamins and minerals cater to cultural preferences, offering a trusted, holistic approach to managing menopausal symptoms and creating a specialized segment with strong consumer appeal.

Europe Market Insights

European market is boosted by the increasing demand for clinically certified and nutritionally regulated products. Strict EU regulations and growing consumer preference for scientifically validated supplements encourage manufacturers to focus on safety, efficacy, and transparency, boosting adoption among health-conscious women across Western and Northern European countries.

In France, the menopause supplements market is experiencing notable growth, driven by the rising popularity of pharmacy-led wellness consultations. French women increasingly depend on pharmacists for guidance on managing menopausal symptoms, including personalized supplement recommendations. This professional support, combined with the trust in regulated pharmacy products, is enhancing the adoption of menopause supplements and stimulating market growth across the country.

Latin America Market Insights

Latin America’s market is being driven by the increasing prevalence of severe menopausal symptoms that require targeted hormonal intervention. Women experiencing intense hot flashes, night sweats, mood swings, and bone density loss are turning to prescription-based hormone therapies, driving higher adoption of clinically monitored hormonal supplements and accelerating market growth.

The growth of Brazil's menopause supplements market is driven by the expansion of private wellness clinics and community health programs targeting women’s health. These initiatives increase awareness of menopause management, provide access to consultations and supplements, and promote adoption of both herbal and clinically formulated products, supporting consistent market growth across urban and semi-urban regions.

Middle East and Africa Market Insights

The Middle East and Africa market growth is stimulated by the growing presence of international health and wellness brands entering urban markets. Increased availability of high-quality supplements combined with rising female health awareness is encouraging the adoption of menopause focused products in countries like the UAE, Saudi Arabia, and South Africa.

Saudi Arabia's menopause supplements market growth is supported by the increasing integration of culturally tailored herbal and natural ingredients in supplement formulations. Products incorporating locally trusted botanicals alongside modern nutrients appeal to regional preferences, enhancing consumer acceptance and creating a specialized niche within the growing women’s health market.

Competitive Landscape

The global menopause supplements market is fragmented, with several key players influencing through product innovation and targeted marketing. Leading companies focus on developing clinically validated, natural, and herbal formulations to cater to diverse consumer preferences. Major players in the market include Bayer AG, Pfizer Inc., Pharmavite LLC, GlaxoSmithKline plc, Amway, Nature’s Way, and others are leveraging R&D, strategic partnerships, and digital distribution to strengthen their market presence.

MyPause Health Pty Ltd.: An emerging market player

MyPause Health, a specialised wellness company, is gaining traction in the market with its focus on natural formulations targeting symptom relief and overall hormonal balance.

• In 2024, the company expanded its distribution through online wellness platforms and strategic partnerships with healthcare providers, increasing accessibility.

By combining scientific research with personalised supplementation solutions, MyPause Health is positioning itself as a prominent emerging player in the global market.

List of Key and Emerging Players in Menopause Supplements Market